Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumors × Tiragolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 12 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Solid Tumors 1 Solid Tumor, Adult 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pancreatic Adenocarcinoma 1 PD-L1-selected Solid Tumors 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Glioblastoma 1

Interventions

Paclitaxel 14 Gemcitabine 11 atezolizumab 9 Carboplatin 9 pembrolizumab 8 Docetaxel 8 Irinotecan 7 Bevacizumab 7 Cetuximab 6 Sunitinib 5 Leucovorin 5 Injections 5 Fluorouracil 5 Cyclophosphamide 5 Capecitabine 5 olaparib 4 navitoclax 4 liposomal doxorubicin 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 temsirolimus 3 spartalizumab 3 pazopanib 3 lenvatinib 3 fludarabine 3 Cisplatin 3 zolbetuximab 2 tocilizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06331598 2024-12-24

IMperator

Hoffmann-La Roche

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡